FOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
FOR LABORATORY RESEARCH PURPOSES ONLY. This compound has not received FDA approval. All information shown is drawn from published laboratory research for educational purposes
Before you continue
This site sells research products exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
GLP-2 is a research-grade lyophilized peptide supplied by Peppy Peptides for laboratory research use only. It is a synthetic dual GIP/GLP-1 receptor agonist and a compound of interest in peptide science, endocrinology and metabolic research.
GLP-2 is a synthetic peptide designed to act at two incretin receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Both are class B G-protein-coupled receptors. Its dual-agonist design lets laboratories study how a single peptide engages two related receptors. It is supplied as a research compound, not a finished pharmaceutical product.
In laboratory and preclinical research, dual GIP/GLP-1 receptor agonists such as GLP-2 have been studied in work involving incretin receptor signaling, glucose metabolism, pancreatic beta-cell biology, endocrine regulation and energy homeostasis. Researchers use GLP-2 in vitro and in preclinical models to compare receptor binding and signal transduction across the GIP and GLP-1 receptors.
GLP-2 is also relevant to structure-activity research on multi-receptor peptides and to comparative studies alongside GLP-1 (single receptor) and GLP-3 (triple agonist).
It means GLP-2 is studied for its engagement with two receptors, the GIP and GLP-1 receptors, rather than one.
No. In this catalog, GLP-2 is the name of a synthetic dual GIP/GLP-1 receptor agonist peptide. It should not be confused with endogenous glucagon-like peptide-2.
Published laboratory research on dual GIP/GLP-1 receptor agonists is indexed on PubMed.
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. This compound has not received FDA approval. All information shown is drawn from clinical studies for educational purposes.
Researcher favourites
Compound details
Molecular profile
Storage requirements
Store lyophilized at −20°C for long-term stability; avoid repeated freeze-thaw cycles; protect from light and moisture
Refrigerate at 2–8°C after reconstitution; use within 4–6 weeks